Abstracts

Application of STOPP Criteria in an Urban Cohort of People Aging With HIV

Background: The validated Screening Tool of Older People’s Prescriptions (STOPP), which identifies potentially inappropriate prescribing (PIP), i.e., treatment for which the potential risk outweighs the potential benefit, may be particularly important for aging people with HIV (PWH) and comorbidities. PIP may exacerbate symptoms and worsen adherence, which is particularly relevant among PWH. Our objectives were…

Uptake of 3+ COVID-19 Vaccine Doses Among People Living With HIV in Ontario, Canada

Background: In Canada, important socio-demographic differences exist between males and females living with HIV which may impact uptake of COVID-19 vaccines. While most people living with HIV are recommended a 2-dose primary series, a 3-dose primary series is recommended for moderately/severely immunocompromised individuals including people living with HIV with AIDS-defining illness, recent TB diagnosis, CD4…

Persistent HIV-1 Plasma Viremia in Patients on Therapy Caused by Macrophage-Tropic Lineage

Background: Antiretroviral therapy (ART) usually suppresses plasma HIV-1 RNA to limits of detection within months of initiation. Rarely, persistent low-level viremia occurs despite good ART adherence due to viral release from a large, clonally-expanded reservoir of HIV-infected CD4 cells. We describe two PWH on ART with persistent, high-level viremia that failed to fully suppress for…

Mycobacterium tuberculosis Infection Dampens the HIV-1 Antibody Response

Background: In prior investigations, we uncovered the impact of Mycobacterium tuberculosis (MTB) infection on the innate immune system in people with HIV (PWH). We showed an improved ability to control HIV and less susceptibility to opportunistic infections in untreated PWH. Intriguingly, it also heightened the risk of non-communicable diseases such as diabetes mellitus. Our exploration…

Using Best-Worst Scaling Experiments to Identify Profiles of Client & Provider Preferences in Zambia

Background: People living with HIV (PLWH) who reengage after falling out of care remain high risk for repeat disengagement, but few tailored reengagement strategies exist to support sustained engagement in this diverse. We used best-worst scaling (BWS) experiments to understand client and health care worker (HCW) preferences for features of reengagement strategies. Methods: We conducted…

Cost-Effectiveness of Differentiated HIV Treatment Delivery in Sub-Saharan Africa: A Modeling Study

Background: Differentiated service delivery (DSD) for HIV treatment is rapidly expanding in Sub-Saharan Africa (SSA). Current evidence suggests that DSD leads to enhanced patient retention but is associated with higher costs compared to the standard of care (SoC) of clinic-based HIV treatment. We conducted a cost-effectiveness (CE) analysis to assess the health and economic implications…

Persistent Challenges With Viral Suppression a Year After Return to Care: Evidence From South Africa

Background: Even though 94% of people living with HIV in South Africa knew their status in 2021, only 74% were actually on antiretroviral therapy (ART) and 67% were virologically suppressed: undermining the potential of ART programmes to improve individual and public health outcomes. Understanding which populations drive this poor treatment success could focus efforts to…